Stay updated on Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial

Sign up to get notified when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.2 to v3.8.0; the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-11-02T12:54:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice appears above the ClinicalTrials.gov page announcing NIH website transition updates and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T16:41:28.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T21:48:15.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:11:34.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content and links. This indicates that access to the study details is currently restricted.
    Difference
    17%
    Check dated 2026-09-21T22:08:21.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel has been added as a participating site, and Qiryat Krinitzi, Israel has been removed from the study locations. This captures the updated geographic footprint of enrolling sites for the trial.
    Difference
    0.1%
    Check dated 2026-09-14T19:20:02.000Z thumbnail image

Stay in the know with updates to Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.